|
"liu cj"的相關文件
顯示項目 1-25 / 153 (共7頁)
1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-01 |
TASL-TSOC Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases
|
Cheng, PN;Chen, WJ;Hou, CJ;Lin, CL;Chang, ML;Wang, CC;Chang, WT;Wang, CY;Lin, CY;Hung, CL;Peng, CY;Yu, ML;Chao, TH;Huang, JF;Huang, YH;Chen, CY;Chiang, CE;Lin, HC;Li, YH;Lin, TH;Kao, CH;Wang, TD;Liu, PY;Wu, YW;Liu, CJ |
| 國家衛生研究院 |
2023-10 |
16-Hydroxybriaranes from the octocoral Briareum stechei
|
Liu, CJ;Wang, CC;Chang, CF;Zhang, MM;Tsou, LK;Wen, ZH;Hwang, TL;Chen, YY;Sung, PJ |
| 國家衛生研究院 |
2022-05-18 |
Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3beta and phosphorylated AKT expression levels
|
Jheng, JR;Hsieh, CF;Chang, YH;Ho, JY;Tang, WF;Chen, ZY;Liu, CJ;Lin, TJ;Huang, LY;Chern, JH;Horng, JT |
| 臺大學術典藏 |
2022-02-24T05:24:58Z |
Effects of tenofovir alafenamide fumarate treatment in pregnant women on maternal viral load reduction and preventing mother-to-infant HBV transmission
|
HUEY-LING CHEN; Lee, CN; Lai, MW; Tsai, MC; Chien, RN; Wen, WH; Chang, KC; Liu, CJ; Ni, YH; Chang, MH |
| 國家衛生研究院 |
2021-03-15 |
Dimethyl sulfoxide stimulates the AhR-Jdp2 axis to control ROS accumulation in mouse embryonic fibroblasts
|
Wuputra, K;Tsai, MH;Kato, K;Yang, YH;Pan, JB;Ku, CC;Noguchi, M;Kishikawa, S;Nakade, K;Chen, HL;Liu, CJ;Nakamura, Y;Kuo, KK;Lin, YC;Chan, TF;Wu, DC;Hou, MF;Huang, SK;Lin, CS;Yokoyama, KK |
| 中山醫學大學 |
2021 |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Liu, CH; Peng, CY; Kao, WY; Yang, SS; Shih, YL; Lin, CL; Tsai, MK; Lee, CY; Chang, CC; Wu, JH; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
|
Liu, CH; Chen, CY; Su, WW; Liu, CJ; Lo, CC; Huang, KJ; Chen, JJ; Tseng, KC; Chang, CY; Peng, CY; Shih, YL; Huang, CS; Kao, WY; Yang, SS; Tsai, MC; Wu, JH; Chen, PY; Su, PY; Hwang, JJ; Fang, YJ; Lee, PL; Tseng, CW; Lee, FJ; Lai, HC; Hsieh, TY; Chang, CC; Chang, CH; Huang, YJ; Kao, JH |
| 中山醫學大學 |
2021 |
Modulating the ERK1/2-MMP1 Axis through Corosolic Acid Inhibits Metastasis of Human Oral Squamous Cell Carcinoma Cells
|
Chen, JL; Lai, CY; Ying, TH; Lin, CW; Wang, PH; Yu, FJ; Liu, CJ; Hsieh, YH |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu, CH; Chen, PY; Chen, JJ; Lo, CC; Su, WW; Tseng, KC; Liu, CJ; Huang, CS; Huang, KJ; Yang, SS; Peng, CY; Tsai, MC; Kao, WY; Chang, CY; Shih, YL; Fang, YJ; Chen, CY; Lee, PL; Huang, JJ; Su, PY; Tseng, CW; Hung, CC; Chang, CH; Huang, YJ; Lai, HC; Chang, CC; Lee, FJ; Hsieh, TY; Kao, JH |
| 中山醫學大學 |
2021 |
Potential Antimetastatic Effect of Timosaponin AIII against Human Osteosarcoma Cells through Regulating the Integrin/FAK/Cofilin Axis
|
Hsieh, YH; Hsu, WH; Yang, SF; Liu, CJ; Lu, KH; Wang, PH; Lin, RC |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Chen, CY; Su, WW; Tseng, KC; Lo, CC; Liu, CJ; Chen, JJ; Peng, CY; Shih, YL; Yang, SS; Huang, CS; Huang, KJ; Chang, CY; Tsai, MC; Kao, WY; Fang, YJ; Chen, PY; Su, PY; Tseng, CW; Huang, JJ; Lee, PL; Lai, HC; Hsieh, TY; Chang, CH; Huang, YJ; Lee, FJ; Chang, CC; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 國家衛生研究院 |
2020-05-13 |
Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors
|
Hsieh, CF;Jheng, JR;Lin, GH;Chen, YL;Ho, JY;Liu, CJ;Hsu, KY;Chen, YS;Chan, YF;Yu, HM;Hsieh, PW;Chern, JH;Horng, JT |
| 中山醫學大學 |
2020 |
IMPACT OF SOFOSBUVIR-BASED VERSUS NON-SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRALS ON RENAL FUNCTION IN CHRONIC HEPATITIS C PATIENTS WITH IMPAIRED RENAL FUNCTION- A LARGE COHORT STUDY FROM THE NATIONWIDE REAL-WORLD HCV REGISTRY PROGRAM (TACR)
|
Yu, ML; Chen, CY; Yi, C; Cheng, PN; Tseng, KC; Lo, CC; Hung, CH; Lin, CY; Chen, CH; Peng, CY; Bair, MJ; Hsieh, TY; Lee, PL; Yang, CC; Lin, CL; Mo, LR; Su, WW; Tsai, WL; Chang, CC; Lin, CC; Hsu, SJ; Liu, CH; Huang, YH; Hu, CT; Liu, CJ; Kao, JH; Lee, MH; Chien, RN; Dai, CY; Tsai, PC |
| 中山醫學大學 |
2020 |
Silencing PROK2 Inhibits Invasion of Human Cervical Cancer Cells by Targeting MMP15 Expression
|
Wu, MH; Wu, PR; Hsieh, YH; Lin, CL; Liu, CJ; Ying, TH |
| 中山醫學大學 |
2020 |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Yang, SS; Peng, CY; Lin, WT; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
|
Chang, WY; Chiu, YC; Chiu, FW; Hsu, YC; Tseng, TC; Cheng, PN; Yang, SS; Liu, CJ; Su, TH; Yang, HC; Liu, CH; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu, CH; Peng, CY; Fang, YJ; Kao, WY; Yang, SS; Lin, CK; Lai, HC; Su, WP; Fang, SU; Chang, CC; Su, TH; Liu, CJ; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
Antiproliferative and Antimetastatic Effects of Praeruptorin C on Human Non-Small Cell Lung Cancer through Inactivating ERK/CTSD Signalling Pathways
|
Liu, CM; Shen, HT; Lin, YA; Yu, YL; Chen, YS; Liu, CJ; Hsieh, YH |
| 國立交通大學 |
2019-04-03T06:39:28Z |
Order parameter of MgB2: A fully gapped superconductor
|
Yang, HD; Lin, JY; Li, HH; Hsu, FH; Liu, CJ; Li, SC; Yu, RC; Jin, CQ |
| 臺大學術典藏 |
2018-09-10T07:11:03Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou, Y.-C.;Yu, M.-W.;Wu, C.-F.;Yang, S.-Y.;Lin, C.-L.;Liu, C.-J.;Shin, W.-L.;Chen, P.-J.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU; Chou, YC; CHUN-JEN LIU; Yu, MW; Wu, CF; Yang, SY; Lin, CL; Liu, CJ; Shih, WL; Chen, PJ; Liaw, YF; Chen, CJ. |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:21Z |
Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; Tseng, TC; CHUN-JEN LIU; Liu, CJ; JIA-HORNG KAO; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T06:33:18Z |
Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients
|
Wang, C.-C.;Liu, C.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lai, My; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users
|
PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; Lai, MY; JIA-HORNG KAO; Chen, DS; Kao, JH.; Lin, C.-.;Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; Lin, CL; Liu, CJ |
顯示項目 1-25 / 153 (共7頁)
1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
|
